Helyx Industries S.p.A. (BIT:HLX)
0.8240
-0.0080 (-0.96%)
Jun 4, 2026, 3:54 PM CET
Helyx Industries Revenue
In the year 2025, Helyx Industries had annual revenue of 1.93M EUR with 151.61% growth. Helyx Industries had revenue of 1.40M in the half year ending December 31, 2025, with 2,702.91% growth.
Revenue
1.93M
Revenue Growth
+151.61%
P/S Ratio
11.11
Revenue / Employee
87.83K
Employees
22
Market Cap
21.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.93M | 1.16M | 151.61% |
| Dec 31, 2024 | 767.93K | 701.72K | 1,059.87% |
| Dec 31, 2023 | 66.21K | -72.23K | -52.17% |
| Dec 31, 2022 | 138.44K | -142.00K | -50.64% |
| Dec 31, 2021 | 280.44K | -325.06K | -53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |